Actively Recruiting
Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG
Led by Peking University Third Hospital · Updated on 2025-09-15
260
Participants Needed
1
Research Sites
291 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this single-center prospective cohort study is to compare perioperative safety metrics and follow-up survival analyses in patients receiving Minimally Invasive Cardiac Surgery Coronary Artery Bypass Grafting(MICS-CABG) and Off-Pump Coronary Artery Bypass(OPCAB). The main question it aims to answer is: Is the bridge vessel patency rate of patients in the MICS-Notouch group noninferior to that of a saphenous vein bridge with conventional open-chest bypass? Participants will be divided into two groups: Exposure group (MICS-Notouch group): non-extracorporeal circulation multiple coronary artery bypass grafting surgery performed under direct visualization of a small incision in the left chest, including the application of LIMA (left internal mammary artery) + SVG (saphenous vein) multiple bypass grafting. Control group (OPCAB group): conventional median chest opening, non-extracorporeal circulation multi-branch coronary artery bypass graft surgery.
CONDITIONS
Official Title
Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with angina limiting daily life or work despite medical treatment who need coronary artery bypass grafting confirmed by coronary angiography
- Patients with calcification of the ascending aorta confirmed by CT who cannot have sidewall clamping
You will not qualify if you...
- Old, large myocardial infarction with no surviving myocardium, significant heart enlargement, EF less than 30%, left ventricular diameter over 70mm, ventricular wall tumor, or severe arrhythmia causing hemodynamic instability
- Valve or other intracardiac surgery planned at the same time
- Expected need for extracorporeal circulation surgery
- Poor myocardial infarction condition, extensive lesions, distal or diffuse stenosis, or severe calcification preventing anastomosis
- Previous open heart surgery
- Preoperative hemodynamic instability requiring emergency surgery
- Terminal malignant tumors, uncontrollable infections, bleeding, severe brain injury, multiple organ failure, or serious organ function impairment
- Inability to tolerate surgery
- Declined participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
G
Gong Yichen, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here